The company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFDA), Lupin said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3i2uvmN
via IFTTT
0 comments:
Post a Comment